Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-11-28
1984-01-03
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 71, 424 9, 435 34, 435 35, 436 64, 436800, 436804, 436813, G01N 130, G01N 2164, G01N 2300, C12Q 104, C12Q 116
Patent
active
044242018
ABSTRACT:
A method for the detection of malignant leukocytic cells which comprises:
REFERENCES:
patent: 3673410 (1972-06-01), Waite et al.
patent: 3743713 (1973-07-01), Kato et al.
patent: 3959455 (1976-05-01), Ansari et al.
Waite et al., Chem. Abstracts, vol. 76, No. 25, Jun. 19, 1972, Abstract No. 150703q.
Morse et al., Chem. Abstracts, vol. 82, No. 23, Jun. 9, 1975, Abstract No. 153152u.
Valinsky et al., Cell, 13 (1978), pp. 487-499.
Easton Thomas G.
Reich Edward
Valinsky Jay E.
Fagelson Anna P.
Rockefeller University
LandOfFree
Employment of a mereyanine dye for the detection of malignant le does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Employment of a mereyanine dye for the detection of malignant le, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Employment of a mereyanine dye for the detection of malignant le will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1031616